Atlas Trials

Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients

Clinical trial NCT02178540 · COMPLETED

Trial details

NCT number
NCT02178540
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2014-08-01
Primary completion
2015-02-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.